Skip to content
Home/Companies/Biotech/Sorriso Pharmaceuticals

Sorriso Pharmaceuticals

Biotech·United States·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Sorriso Pharmaceuticals?

Sorriso Pharmaceuticals is an American Biotech company, currently owned by Lundbeckfonden BioCapital since 2021.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Lundbeckfonden BioCapital
Investor
Lundbeckfonden BioCapital
Lundbeckfonden BioCapital · 2009 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Lundbeckfonden BioCapital

Other portfolio companies in the same fund.

QuantumCell
Active
BiotechDenmark· 2025
Kvantify
Active
Deep TechDenmark· 2024
Dania Therapeutics
Active
BiotechDenmark· 2023
Epoqe Pharma
Active
BiotechDenmark· 2021
Lexeo Therapeutics
Exited 2023
BiotechUS· 2021
Notify Therapeutics
Active
BiotechDenmark· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Sorriso Pharmaceuticals?

Sorriso Pharmaceuticals is currently owned by Lundbeckfonden BioCapital, through Lundbeckfonden BioCapital, since 2021.

When did Lundbeckfonden BioCapital acquire Sorriso Pharmaceuticals?

Lundbeckfonden BioCapital acquired Sorriso Pharmaceuticals in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue